iShares Trust iShares iBonds Dec 2035 Term Corporate ETF (ARCA: IBCA)

最新ニュース iShares Trust iShares iBonds Dec 2035 Term Corporate ETF (ARCA:IBCA)

Intervest Bancshares Corp.

NASDAQ

The Fund may also invest in U.S. government securities, short-term paper, cash and cash equivalents, including shares of money market funds advised by BFA or its affiliates. The Fund is a term fund that will terminate on or about December 15, 2035, at which time it will distribute its remaining net assets to shareholders pursuant to a plan of liquidation.

iShares iBonds Dec 2035 Term Corporate ETF

iShares Trust iShares iBonds Dec 2035 Term Corporate ETF

BlackRock, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) will release its first-quarter financial results before the opening <a href="https://www.benzinga.com/quote/BLK/earnings">bell on Friday, April 11</a>.
Analysts expect the company to report quarterly earnings at $10.21 per share, up from $9.81 per share in the year-ago period. BlackRock projects quarterly revenue of $5.31 billion, compared to $4.73 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
BlackRock recently broadened its fixed-income lineup with two new target maturity ETFs. The iShares iBonds Dec 2035 Term Corporate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBCA#NYSE">IBCA</a>) and the iShares iBonds Oct 2035 Term TIPS ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBIL#NYSE">IBIL</a>) blend the features of conventional bonds with the convenience of stock-like trading.
BlackRock shares fell 4.3% to close at $858.78 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/blk/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Barclays analyst Benjamin Budish maintained an Overweight rating and cut the price target from $1,210 to $950 on April 7, 2025. This analyst has an accuracy rate of 73%.</li>
<li>B of A Securities analyst Craig Siegenthaler maintained a Buy rating and lowered the price target from $1,196 to $1,178 on April 3, 2025. This analyst has an accuracy rate of 74%.</li>
<li>UBS analyst Brennan Hawken maintained a Neutral rating and increased the price target from $1,017 to $1,045 on Jan. 21, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Citigroup analyst William Katz maintained a Buy rating and increased the price target from $1,150 to $1,200 on Dec. 23, 2024. This analyst has an accuracy rate of 69%.</li>
<li>Goldman Sachs analyst Alexander Blostein maintained a Buy rating and raised the price target from $960 to $1,040 on Oct. 3, 2024. This analyst has an accuracy rate of 71%.</li>
</ul>
Considering buying BLK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="428" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/11025909/image-71-1024x428.png" alt="" class="wp-image-867229" style="width:533px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/11025909/image-71-1024x428.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/11025909/image-71-300x125.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/11025909/image-71-768x321.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/11025909/image-71.png 1451w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44734419/top-2-real-estate-stocks-that-may-keep-you-up-at-night-this-month">Top 2 Real Estate Stocks That May Keep You Up At Night This Month</a> </li>
</ul>
Photo via Shutterstock

Earnings

News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

IBCA

iShares Trust iShares iBonds Oct 2035 Term TIPS ETF

IBIL

BlackRock Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

BlackRock Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) broadened its fixed-income lineup with two new <a href="https://www.benzinga.com/etfs">target maturity ETFs</a>.
The iShares iBonds Dec 2035 Term Corporate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBCA#NYSE">IBCA</a>) and the iShares iBonds Oct 2035 Term TIPS ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBIL#NYSE">IBIL</a>) blend the features of conventional bonds with the convenience of stock-like trading.
Both IBCA and IBIL, which launched Wednesday, can be useful parts of a bond ladder <a href="https://www.sec.gov/Archives/edgar/data/1100663/000119312525062392/d887896d497k.htm">strategy</a>. This approach involves holding bond ETFs with various maturity dates so that investors can control interest rate risk and continue to earn a steady income.
When the bonds mature, investors can reinvest in new ones, with the potential advantage of higher interest rates. This flexibility renders target maturity ETFs a sensible option for those who wish to manage risk versus return in shifting market conditions.
Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/03/44518378/crypto-with-controlled-risk-how-fortunas-new-bitcoin-fund-aims-to-manage-volatility-maximize-returns">Crypto With Controlled Risk: How Fortuna&#8217;s New Bitcoin Fund Seeks To Manage Volatility, Enhance Returns</a>
IBCA monitors and replicates the Bloomberg December 2035 Maturity Corporate Index but can also hold U.S. government securities, short-term paper, cash or cash equivalents, and money market funds. Under its prospectus, IBCA will liquidate on about December 15, 2035.
At its launch, IBCA&#8217;s portfolio concentrated on consumer goods and services and energy companies. It is a strong option for investors wanting long-term corporate bond exposure with a specific maturity date.
IBIL, on the other hand, is <a href="https://www.ishares.com/us/products/342148/ishares-ibonds-oct-2035-term-tips-etf">designed </a>for investors who want protection against inflation. It tracks the ICE 2035 Maturity US Inflation-Linked Treasury Index, which is comprised of inflation-indexed U.S. Treasury securities due in 2035.
The majority of IBIL assets are invested in the index&#8217;s component securities, although at most 10% may be invested in options, futures, and swap agreements. The fund will expire around October 15, 2035, for a disciplined approach to inflation-protection investing.
BlackRock portfolio managers James Mauro and Karen Uyehara oversee IBC and IBIL. Both funds have a low-cost ratio of 0.10%. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/events/25/03/44497987/xtrackers-etfs-offer-unique-exposure-to-hottest-themes-in-market-the-internet-era-times-two">Xtrackers ETFs Offer Unique Exposure To Hottest Themes In Market: &#8216;The Internet Era Times Two&#8217;</a></li>
</ul>
Image: Shutterstock

New ETFs

ETFs

BlackRock Unveils New iShares iBonds ETFs For Fixed-Income Investors

From 13G: Hilary Shane Reports 5.31% Stake In Intervest Bancshares Corporation

Intervest Bancshares Corp. (NASDAQ: <a class="ticker" href="/stock/ibca#NASDAQ">IBCA</a>) reports Q3 EPS of $0.19.

Intervest Bancshares Corp. Reports Q3 EPS of $0.19

Expedia (NASDAQ: <a class="ticker" href="/stock/expe#NASDAQ">EXPE</a>) shares reached a new 52-week high of $84.13 after the company reported upbeat results for the second quarter. Analysts at Raymond James upgraded Expedia from Market Perform to Outperform.
Intervest Bancshares (NASDAQ: <a class="ticker" href="/stock/ibca#NASDAQ">IBCA</a>) shares touched a new 52-week high of $9.07 after the company agreed to be acquired by Bank of the Ozarks (NASDAQ: <a class="ticker" href="/stock/ozrk#NASDAQ">OZRK</a>) in an all-stock transaction.
Cambrex (NYSE: <a class="ticker" href="/stock/cbm#NYSE">CBM</a>) shares touched a new 52-week high of $22.86 after the company reported stronger-than-expected second-quarter results and issued a strong FY14 earnings forecast. 
Spirit AeroSystems Holdings (NYSE: <a class="ticker" href="/stock/spr#NYSE">SPR</a>) shares reached a new 52-week high of $35.95 after the company posted a profit in the second quarter and raised its forecast for FY14.

Intraday Update

Movers

EXPE

OZRK

Stocks Hitting 52-Week Highs

CBD Energy (NASDAQ: CBDE) shares surged 38.82% to $3.29 after the company reported that it has secured a 64 megawatt, $112,000,000 solar project in Thailand.
Bally Technologies (NYSE: <a class="ticker" href="/stock/byi#NYSE">BYI</a>) shares jumped 30.59% to $78.57 after the company agreed to be acquired by Scientific Games (NASDAQ: <a class="ticker" href="/stock/sgms#NASDAQ">SGMS</a>) for $83.30 per share in cash. 
Tandem Diabetes Care (NASDAQ: <a class="ticker" href="/stock/tndm#NASDAQ">TNDM</a>) rose 20.34% to $15.03 after the company reported better-than-expected Q2 earnings.
Intervest Bancshares (NASDAQ: <a class="ticker" href="/stock/ibca#NASDAQ">IBCA</a>) shares gained 16.85% to $9.32 after the company agreed to be acquired by Bank of the Ozarks (NASDAQ: <a class="ticker" href="/stock/ozrk#NASDAQ">OZRK</a>) in an all-stock transaction.
Imperva (NYSE: <a class="ticker" href="/stock/impv#NYSE">IMPV</a>) climbed 15.99% to $25.71 on strong Q2 results and FY14 outlook.
Scientific Games (NASDAQ: <a class="ticker" href="/stock/sgms#NASDAQ">SGMS</a>) climbed 14.17% to $9.75 after the company announced its plans to buy Bally Technologies (NYSE: <a class="ticker" href="/stock/byi#NYSE">BYI</a>) in a $5.1 billion deal. 
LinkedIn (NYSE: <a class="ticker" href="/stock/lnkd#NYSE">LNKD</a>) rose 7.91% to $194.92 after the company reported upbeat second-quarter results and issued a strong outlook for the current quarter. 
SurModics (NASDAQ: <a class="ticker" href="/stock/srdx#NASDAQ">SRDX</a>) gained 6.37% to $20.20 on better-than-expected FQ3 earnings.
Expedia (NASDAQ: <a class="ticker" href="/stock/expe#NASDAQ">EXPE</a>) surged 4.51% to $83.00 after the company reported upbeat results for the second quarter. Analysts at Raymond James upgraded Expedia from Market Perform to Outperform.

IMPV

LNKD

SGMS

SRDX

TNDM

Morning Market Movers 

Intervest Bancshares Corp. (NASDAQ: <a class="ticker" href="/stock/ibca#NASDAQ">IBCA</a>) reports Q1 EPS of $0.17.

Intervest Bancshares Corp. Reports Q1 EPS of $0.17

Intervest Bancshares Corp. (NASDAQ: <a class="ticker" href="/stock/ibca#NASDAQ">IBCA</a>) reports Q2 EPS of $0.14 versus $0.11 in the same quarter last year.

Intervest Bancshares Corp. Reports Q2 EPS of $0.14, Up 27% YOY

Below are highlights from Benzinga's daily coverage of small cap securities making big moves:

Intervest Bancshares

Shares of Intervest Bancshares (NASDAQ: <a class="ticker" href="/stock/ibca#NASDAQ">IBCA</a>), the New York-based parent company of Intervest National Bank, rose 10% Wednesday on 4.5 times average volume.

Intervest Bancshares reported Wednesday that its net earnings for the fourth quarter of 2012 increased to $3.1 million, or $0.14 per common share, from $2.7 million, or $0.13 per share, for the fourth quarter of 2011, and net earnings for the full year 2012 increased to $10.4 million, or $0.48 per share, from $9.5 million, or $0.45 per share, for 2011.

Intervest Bancshares closed at $4.39 on Wednesday.

Unilife Corp

Shares of Unilife Corp (NASDAQ: <a class="ticker" href="/stock/unis#NASDAQ">UNIS</a>), the York, PA developer of injectable drug delivery systems, rose 13% Wednesday on 5 times average volume.

Unilife was the suject of a <a href="http://seekingalpha.com/article/1116461-buy-these-cheap-2-tech-dogs-for-major-potential-gains-in-2013?source=yahoo">Seeking Alpha</a> blog post on Wednesday.

Unilife Corp closed at $2.55 on Wednesday.

Kingold Jewelry

Shares of Kingold Jewelry (NASDAQ: <a class="ticker" href="/stock/kgji#NASDAQ">KGJI</a>), the China-based manufacturer and designer of high quality 24-karat gold jewelry, rose 15% Wednesday on almost 8 times average volume.

Kingold Jewelry announced Wednesday that the Company has signed a Gold Leasing Agreement with China Construction Bank's Wuhan Jiang'An branch. The Agreement is similar to a revolving credit line, with CCB providing Kingold a reusable credit line of up to RMB250 million (approximately US$40.2 million); however, draw downs under the facility (and repayment thereunder) will be made in gold rather than currency. 

Kingold Jewelry, closed at $2.65 on Wednesday.

The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment.

Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.

Long Ideas

Short Ideas

Small Cap

Global

After-Hours Center

KGJI

UNIS

Benzinga's Small Cap Movers for Wednesday January 16, 2013

Intervest Bancshares (NASD: IBCA) reports third-quarter EPS of $0.10.

Intervest Bancshares Reports Q3 EPS $0.10

Cemex (NYSE: <a class="ticker" href="/stock/cx#NYSE">CX</a>) Q3 2012 
Charles Schwab (NYSE: <a class="ticker" href="/stock/schw#NYSE">SCHW</a>) Q3 2012 
Citigroup (NYSE: <a class="ticker" href="/stock/c#NYSE">C</a>) Q3 2012 
Gannett (NYSE: <a class="ticker" href="/stock/gci#NYSE">GCI</a>) Q3 2012 
Intervest Bancshares (NYSE: <a class="ticker" href="/stock/ibca#NYSE">IBCA</a>) Q3 2012

Guidance

SCHW

Earnings for Monday October 15, 2012 Pre-Market

Below are the top credit services stocks on the NASDAQ in terms of PEG ratio.

Intervest Bancshares Corp (NASDAQ: <a class="ticker" href="/stock/ibca#NASDAQ">IBCA</a>) has a PEG ratio of 0.50. IBCA's trailing-twelve-month operating margin is 61.51%.

DFC Global Corp (NASDAQ: <a class="ticker" href="/stock/dllr#NASDAQ">DLLR</a>) has a PEG ratio of 0.52. DLLR's trailing-twelve-month ROE is 20.25%.

Encore Capital Group Inc (NASDAQ: <a class="ticker" href="/stock/ecpg#NASDAQ">ECPG</a>) has a PEG ratio of 0.72. ECPG's trailing-twelve-month operating margin is 25.77%.

World Acceptance Corporation (NASDAQ: <a class="ticker" href="/stock/wrld#NASDAQ">WRLD</a>) has a PEG ratio of 0.86. WRLD's trailing-twelve-month revenue is $504.20 million.

<a href="http://www.benzinga.com/trading-ideas">Trading Ideas.</a>

DLLR

ECPG

WRLD

Top 4 NASDAQ Stocks In The Credit Services Industry With The Lowest PEG Ratio

Intervest Bancshares Reports Q2 EPS of $0.12 vs. $0.06 Est

Cree Inc (NASDAQ: <a class="ticker" href="/stock/cree#NASDAQ">CREE</a>) dipped 15.64% to $52.90 in the pre-market session. CREE issued weaker-than-expected Q3 profit and revenue projections.
Depomed Inc (NASDAQ: <a class="ticker" href="/stock/depo#NASDAQ">DEPO</a>) fell 12.46% to $5.76 in the pre-market session. DEPO reported that it is looking to resolve dispute with Abbott Laboratories (NYSE: <a class="ticker" href="/stock/abt#NYSE">ABT</a>) over a disagreement about the launch of a pain drug candidate. 
WSB Holdings Inc (NASDAQ: <a class="ticker" href="/stock/wsb#NASDAQ">WSB</a>) moved down 8.62% to $2.65 in the pre-market session. WSB's trailing-twelve-month profit margin is -43.08%.
Intervest Bancshares Corp (NASDAQ: <a class="ticker" href="/stock/ibca#NASDAQ">IBCA</a>) dropped 6.46% to $2.75 in the pre-market trading. IBCA reported its Q4 net earnings at $0.02 per share, down from $0.04 per share, in the year-ago quarter.
Read more <a href="http://www.benzinga.com/markets">from Benzinga's Markets.</a>

CREE

DEPO

Benzinga's Top Pre-Market NASDAQ Losers (CREE, DEPO, WSB, IBCA)

Intervest Bancshares Corporation (NASDAQ: <a class="ticker" href="/stock/ibca#NASDAQ">IBCA</a>), parent company of Intervest National Bank, today reported its financial results for the fourth quarter of 2010. 
Financial Highlights: 
Net earnings for the fourth quarter of 2010 amounted to $0.4 million, or $0.02 per diluted common share, compared to a net loss of $0.7 million, or $0.07 per share, for the third quarter of 2010), and net earnings of $0.3 million, or $0.04 per share, for the same quarter a year ago. 
Pre-tax earnings before deducting provisions for loan and real estate losses and real estate expenses amounted to $6.6 million in Q4-10, compared to $4.9 million in Q3-10 and $7.8 million in Q4-09. 
Net interest margin for Q4-10 was 2.06%, compared to 1.98% in Q3-10 and 2.04% in Q4-09.

Intervest Bancshares Corporation Reports Fourth Quarter EPS of $.02

Intervest Bancshares Corporation (Nasdaq: <a class="ticker" href="/stock/ibca#Nasdaq">IBCA</a>), today announced that the underwriter of its public offering of common stock, which closed on October 20, 2010, exercised a portion of its over-allotment option to purchase additional shares of the Company's common stock. 
The option was granted in connection with the Company's public offering of 10,600,000 shares of common stock at a public offering price of $1.95 per share. The sale of the additional shares pursuant to the over-allotment option closed today.

Offerings

Intervest Bancshares Corporation Announces Exercise of Over-Allotment   

Intervest Bancshares Corporation (NASDAQ: <a class="ticker" href="/stock/ibca#NASDAQ">IBCA</a>) today reported a net loss for the third quarter of 2010 of $0.7 million, or $0.07 per diluted common share, compared to net income of $0.3 million, or $0.04 per share, for the third quarter of 2009.
Results for both periods included $0.4 million of preferred dividend requirements related to the Company's participation in TARP. The change in results was primarily due to a $1.8 million increase in the combined provision for loan and real estate losses and a $0.6 million non-recurring charge related to the conversion of Intervest National Bank's core data processing to a lower-cost provider. 
These items were partially offset by a $1.3 million decrease in carrying expenses associated with a lower level of nonperforming assets. At September 30, 2010, the Company's common stock book value per share was $15.26.

Intervest Bancshares Corporation Reports Net Loss of $0.7 Million

Below are interesting stocks on the NASDAQ with the lowest P/B ratio. 
Intervest Bancshares Corp (NASDAQ: <a href="/stock/ibca">IBCA</a>) has a price to book ratio of 0.142. The sales growth estimate for this quarter is 44.6%. IBCA shares have declined by 48.41% over the past 52 weeks. 
Yadkin Valley Financial Corp (NASDAQ: <a href="/stock/yavy">YAVY</a>) has a price to book ratio of 0.37. The sales growth estimate for this quarter is 85.7%. IBCP shares have plummeted by 74.35% over the past 52 weeks.
Independent Bank Corporation (NASDAQ: <a href="/stock/ibcp">IBCP</a>) has a price to book ratio of 0.39. The sales growth estimate for this quarter is 27.0%. IBCP shares have slipped by 60.81% over the past 52 weeks.
Taylor Capital Group Inc (NASDAQ: <a href="/stock/tayc">TAYC</a>) has a price to book ratio of 0.55. The sales growth estimate for this quarter is 39.7%. TAYC shares have slid by 46.92% over the past 52 weeks.
East West Bancorp Inc (NASDAQ: <a href="/stock/ewbc">EWBC</a>) has a price to book ratio of 0.57. The sales growth estimate for this quarter is 134.4%. Keefe Bruyette upgraded EWBC from “market perform” to “outperform.”

Comments

iShares Trust iShares iBonds Dec 2035 Term Corporate ETF

ニュース

最新ニュース iShares Trust iShares iBonds Dec 2035 Term Corporate ETF (ARCA:IBCA)

ニュース

パートナーシップ

ベンジンガ・グローバル